您的位置: 首页 > 农业专利 > 详情页

Treating critically ill patients with intravenous ibuprofen
专利权人:
Cumberland Pharmaceuticals Inc.
发明人:
Pavliv Leo,Rock Amy Dix
申请号:
US201715484349
公开号:
US9931311(B2)
申请日:
2017.04.11
申请国别(地区):
美国
年份:
2018
代理人:
Davidson, Davidson & Kappel, LLC
摘要:
Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充